NCT05784311View on ClinicalTrials.gov

Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)

PHASE4RecruitingINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

January 31, 2026

Conditions
Pancreatic Cancer
Interventions
DRUG

Cefuroxime

1500mg IV cefuroxime thrice daily during five days.

DRUG

Metronidazole

500mg IV metronidazole thrice daily during five days.

Trial Locations (11)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Unknown

NOT_YET_RECRUITING

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

RECRUITING

Amsterdam University Medical Center, Amsterdam

RECRUITING

Amphia Ziekenhuis, Breda

RECRUITING

Catharina Ziekenhuis, Eindhoven

RECRUITING

Medisch Spectrum Twente, Enschede

RECRUITING

Groningen University Medical Center, Groningen

RECRUITING

Maastricht University Medical Center, Maastricht

RECRUITING

Radboud University Medical Center, Nijmegen

RECRUITING

Erasmus MC Cancer Institute, Rotterdam

RECRUITING

Regional Academic Cancer Center Utrecht, Utrecht

All Listed Sponsors
lead

Leiden University Medical Center

OTHER